IGF-1 LR3
Used to drive muscle growth. A long-acting form of insulin-like growth factor 1, with limited human safety data and a real side effect profile, handle with discipline.
IGF-1 LR3: Used to drive muscle growth. A long-acting form of insulin-like growth factor 1, with limited human safety data and a real side effect profile, handle with discipline. IGF-1 LR3 is a long-acting form of insulin-like growth factor 1.
IGF-1 LR3 is a long-acting form of insulin-like growth factor 1. Used for muscle anabolism, but human safety data is thin and the side effect profile (low blood sugar, organ growth concerns) is real. Treat carefully, short cycles only.
Mecasermin (Increlex) approved 2005 for severe primary IGF-1 deficiency. IGF-1 LR3 specifically (research analog) is NOT FDA approved.
FDA flagged as significant safety risk; restricted from compounding pharmacies.
Increlex prescribed by pediatric endocrinology for IGF-1 deficiency. IGF-1 LR3 is not prescribed.
Who it's for
- →Experienced users who already have GH-axis baseline
- →Short, focused anabolism cycles
What to expect
- Week 1
Pumps and fullness in trained muscle. Mild hypoglycemia risk.
- Week 4
Nutrient partitioning shifts noticeably. Plateau approaching by week 4.
- Week 8
Cycle endpoint already passed. Cycle off well before this point.
Looking at IGF-1 LR3? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for IGF-1 LR3.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Long Arg3 IGF-1, a modified IGF-1 with arginine at position 3 and an N-terminal extension. Resists binding to IGFBPs (which normally sequester IGF-1), giving it ~3x longer half-life and stronger systemic activity than native IGF-1.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy (real concern with IGF-1)
- ⚠Diabetic retinopathy
- ⚠Pregnancy / nursing
- ⚠Hypoglycemia-prone
Bloodwork to monitor
- • Fasting glucose every 2 weeks
- • IGF-1 baseline + at week 4
Common mistakes
- • Running it longer than 4 weeks
- • Dosing fasted (hypoglycemia)
- • Stacking with insulin or insulin-sensitizers without monitoring
Drug & supplement interactions
- ⚠Insulin: severe hypoglycemia risk, eat carbs near dose
- ⚠Glucocorticoids antagonize IGF-1 effects
- ⚠Cytotoxic chemotherapy: avoid (theoretical malignancy concern)
Community patterns
New to IGF-1 LR3? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if IGF-1 LR3 changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about IGF-1 LR3 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is IGF-1 LR3?+
Is IGF-1 LR3 FDA approved?+
Is IGF-1 LR3 legal?+
Is IGF-1 LR3 banned by WADA?+
Are you still natty after taking IGF-1 LR3?+
Do doctors prescribe IGF-1 LR3?+
What's the typical dose of IGF-1 LR3?+
What are the side effects of IGF-1 LR3?+
How long until IGF-1 LR3 starts working?+
What can you stack with IGF-1 LR3?+
Where do people get IGF-1 LR3?+
IGF-1 LR3 vs IGF-1 DES, which is better?+
Head-to-head with IGF-1 LR3
More in GH-axis
Recombinant human growth hormone, the protein itself, not a peptide that nudges your body to make more. Highest legal-risk compound in this catalog.
Oral ghrelin mimetic. Bumps GH and IGF-1 without injections. Strong appetite stimulation is the trade-off.
Bumps your natural growth-hormone pulses without hitting cortisol or prolactin. A selective GH secretagogue.
Pairs with Ipamorelin to amplify your natural growth-hormone pulses. A GHRH analog whose 'no-DAC' version stays short-acting on purpose.